Intravenous immunoglobulin attenuates experimental autoimmune arthritis by inducing reciprocal regulation of th17 and treg cells in an interleukin-10- dependent manner

Arthritis and Rheumatology

Volumn 66, Issue 7, 2014, Pages 1768-1778

  Lee, Seon Yeong ^a   Jung, Young Ok ^b   Ryu, Jun Geol ^a   Kang, Chang Min ^a   Kim, Eun Kyung ^a   Son, Hye Jin ^a   Yang, Eun Ji ^a   Ju, Ji Hyeon ^c   Kang, Young Sun ^d   Park, Sung Hwan ^c   Kim, Ho Youn ^c   Cho, Mi La ^a  

^a The Catholic University of Korea   (South Korea)

^b Hallym University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; CYTOKINE; FC RECEPTOR IIB; IMMUNOGLOBULIN; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GERMINAL CENTER; HELPER CELL; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; TH17 CELL; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; FLOW CYTOMETRY; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-10; MALE; MICE; MICE, INBRED DBA; RECEPTORS, IGG; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; UP-REGULATION;

EID: 84903462346     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38627     Document Type: Article

References (49)

1. Gelfand EW,. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med 2012; 367: 2015-25.
2. Nimmerjahn F, Ravetch JV,. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008; 26: 513-33.
3. Hundt M, Manger K, Dorner T, Grimbacher B, Kalden P, Rascu A, et al. Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin. Rheumatology (Oxford) 2000; 39: 1301-2.
4. Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, et al. A study of 20 SLE patients with intravenous immunoglobulin-clinical and serologic response. Lupus 1999; 8: 705-12.
5. Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dayan Y, et al. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 1999; 119: 231-8.
6. Samuelsson A, Towers TL, Ravetch JV,. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291: 484-6.
7. Shioji K, Kishimoto C, Sasayama S,. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells. Circ Res 2001; 89: 540-6.
8. Finberg RW, Newburger JW, Mikati MA, Heller AH, Burns JC,. Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood. J Pediatr 1992; 120: 376-80.
9. Casadei DH, del C Rial M, Opelz G, Golberg JC, Argento JA, Greco G, et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001; 71: 53-8.
10. Sokos DR, Berger M, Lazarus HM,. Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 117-30.
11. Bach JF,. Regulatory T cells under scrutiny. Nat Rev Immunol 2003; 3: 189-98.
12. + regulatory T cells that express Toll-like receptors. J Exp Med 2003; 197: 397-401.
13. + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005; 140: 360-7.
14. + regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann Rheum Dis 2009; 68: 744-50.
15. Nakae S, Nambu A, Sudo K, Iwakura Y,. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 6173-7.
16. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y,. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 2003; 100: 5986-90.
17. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593-603.
18. Katz Y, Nadiv O, Beer Y,. Interleukin-17 enhances tumor necrosis factor α-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes. Arthritis Rheum 2001; 44: 2176-84.
19. Adamopoulos IE, Chao CC, Geissler R, Laface D, Blumenschein W, Iwakura Y, et al. Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors. Arthritis Res Ther 2010; 12: R29.
20. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
21. pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112: 2340-52.
22. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG,. Follicular helper T cells: lineage and location. Immunity 2009; 30: 324-35.
23. Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG,. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol 2009; 10: 375-84.
24. Zhang X, Ing S, Fraser A, Chen M, Khan O, Zakem J, et al. Follicular helper T cells: new insights into mechanisms of autoimmune diseases. Ochsner J 2013; 13: 131-9.
25. Maddur MS, Sharma M, Hegde P, Lacroix-Desmazes S, Kaveri SV, Bayry J,. Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations. J Clin Immunol 2013; 33 Suppl 1: S62-6.
26. Kessel A, Ammuri H, Peri R, Pavlotzky ER, Blank M, Shoenfeld Y, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol 2007; 179: 5571-5.
27. Siragam V, Brinc D, Crow AR, Song S, Freedman J, Lazarus AH,. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? J Clin Invest 2005; 115: 155-60.
28. H2 pathway. Nature 2011; 475: 110-3.
29. Kim WU, Lee WK, Ryoo JW, Kim SH, Kim J, Youn J, et al. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. Arthritis Rheum 2002; 46: 1109-20.
30. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005; 11: 936-43.
31. Tha-In T, Bayry J, Metselaar HJ, Kaveri SV, Kwekkeboom J,. Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 2008; 29: 608-15.
32. + regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 2008; 111: 715-22.
33. Jia S, Li C, Wang G, Yang J, Zu Y,. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol 2010; 162: 131-7.
34. Liu Z, Davidson A,. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012; 18: 871-82.
35. Ma J, Zhu C, Ma B, Tian J, Baidoo SE, Mao C, et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol 2012; 2012: 827480.
36. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 2011; 17: 983-8.
37. Chen X, Howard OM, Oppenheim JJ,. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J Immunol 2007; 178: 6123-9.
38. Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J,. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31: 784-8.
39. Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R, et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One 2011; 6: e17739.
40. Crotty S,. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29: 621-63.
41. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26: 371-81.
42. Johnston RJ, Choi YS, Diamond JA, Yang JA, Crotty S,. STAT5 is a potent negative regulator of TFH cell differentiation. J Exp Med 2012; 209: 243-50.
43. Bruhns P, Samuelsson A, Pollard JW, Ravetch JV,. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 2003; 18: 573-81.
44. Espeli M, Clatworthy MR, Bokers S, Lawlor KE, Cutler AJ, Kontgen F, et al. Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity. J Exp Med 2012; 209: 2307-19.
45. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O', Garra A,. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-22.
46. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
47. + T cell population of rheumatoid arthritis patients. Immunol Lett 2010; 127: 150-6.
48. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A,. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
49. Gu Y, Yang J, Ouyang X, Liu W, Li H, Bromberg J, et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 2008; 38: 1807-13.